|
GB0603683D0
(en)
*
|
2006-02-23 |
2006-04-05 |
Novartis Ag |
Organic compounds
|
|
JP5059119B2
(ja)
|
2006-12-14 |
2012-10-24 |
シェーリング コーポレイション |
操作された抗ｔｓｌｐ抗体
|
|
EP2803675A3
(en)
*
|
2008-01-25 |
2014-12-24 |
Amgen, Inc |
Ferroportin antibodies and methods of use
|
|
EP3594356A1
(en)
*
|
2009-11-04 |
2020-01-15 |
Merck Sharp & Dohme Corp. |
Engineered anti-tslp antibody
|
|
AU2011305306C1
(en)
*
|
2010-09-22 |
2016-02-18 |
Amgen Inc. |
Carrier immunoglobulins and uses thereof
|
|
WO2013067051A1
(en)
*
|
2011-11-03 |
2013-05-10 |
Merck Sharp & Dohme Corp. |
Biomarkers for tslp treatment
|
|
KR20180137614A
(ko)
*
|
2012-04-27 |
2018-12-27 |
노보 노르디스크 에이/에스 |
사람 cd30 리간드 항원 결합 단백질
|
|
UY35148A
(es)
|
2012-11-21 |
2014-05-30 |
Amgen Inc |
Immunoglobulinas heterodiméricas
|
|
WO2014144817A2
(en)
|
2013-03-15 |
2014-09-18 |
Amgen Inc. |
Inhibitory polypeptides specific to wnt inhibitors
|
|
CN104371019B
(zh)
*
|
2013-08-13 |
2019-09-10 |
鸿运华宁（杭州）生物医药有限公司 |
一种能与glp-1r特异性结合的抗体及其与glp-1的融合蛋白质
|
|
TW201605896A
(zh)
|
2013-08-30 |
2016-02-16 |
安美基股份有限公司 |
Gitr抗原結合蛋白
|
|
EP3041863A4
(en)
|
2013-09-05 |
2017-08-16 |
Amgen Inc. |
Fc-containing molecules exhibiting predictable, consistent, and reproducible glycoform profiles
|
|
WO2015118124A1
(en)
*
|
2014-02-06 |
2015-08-13 |
Vib Vzw |
Thymic stromal lymphopoietin receptor antagonist
|
|
CA3193070A1
(en)
|
2014-05-07 |
2015-11-12 |
Amgen Inc. |
Autoinjector with shock reducing elements
|
|
MX377275B
(es)
|
2014-05-16 |
2025-03-07 |
Amgen Inc |
Ensayo para detectar poblaciones celulares linfocitos t colaboradores 1 (th1) y linfocitos t colaboradores (th2).
|
|
KR20170016335A
(ko)
|
2014-06-03 |
2017-02-13 |
암겐 인코포레이티드 |
약물 전달 디바이스의 사용자를 보조하기 위한 디바이스들 및 방법들
|
|
MX392725B
(es)
|
2014-10-14 |
2025-03-24 |
Amgen Inc |
Dispositivo de inyeccion de farmaco con indicadores visuales y audibles.
|
|
AU2015335743B2
(en)
|
2014-10-23 |
2020-12-24 |
Amgen Inc. |
Reducing viscosity of pharmaceutical formulations
|
|
EP3233159B1
(en)
|
2014-12-19 |
2020-03-04 |
Amgen Inc. |
Drug delivery device with live button or user interface field
|
|
AU2016220141B2
(en)
|
2015-02-17 |
2018-07-12 |
Amgen Inc. |
Drug delivery device with vacuum assisted securement and/or feedback
|
|
EP3261690B1
(en)
|
2015-02-27 |
2021-12-15 |
Amgen Inc. |
Drug delivery device having a needle guard mechanism with a tunable threshold of resistance to needle guard movement
|
|
UY36578A
(es)
*
|
2015-03-11 |
2016-09-30 |
Glaxosmithkline Ip Dev Ltd |
Proteínas de unión a tslp
|
|
SG10202002131PA
(en)
|
2015-05-21 |
2020-05-28 |
Harpoon Therapeutics Inc |
Trispecific binding proteins and methods of use
|
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
|
UY36889A
(es)
*
|
2015-09-09 |
2017-04-28 |
Novartis Ag |
Moléculas de unión a linfopoyetina estromal timica (tslp) y métodos de uso de las moléculas
|
|
KR20180042433A
(ko)
|
2015-09-09 |
2018-04-25 |
노파르티스 아게 |
흉선 기질 림포포이에틴 (tslp)-결합 항체 및 항체의 사용 방법
|
|
ES2755717T3
(es)
|
2015-12-09 |
2020-04-23 |
Amgen Inc |
Autoinyector con tapa de señalización
|
|
US11154661B2
(en)
|
2016-01-06 |
2021-10-26 |
Amgen Inc. |
Auto-injector with signaling electronics
|
|
KR20180104036A
(ko)
|
2016-01-22 |
2018-09-19 |
머크 샤프 앤드 돔 코포레이션 |
항-응고 인자 xi 항체
|
|
GB201615588D0
(en)
*
|
2016-09-14 |
2016-10-26 |
Glaxosmithkline Ip Dev Ltd |
TSLP Binding Proteins
|
|
DK3429663T3
(da)
|
2016-03-15 |
2020-09-28 |
Amgen Inc |
Reduktion af sandsynligheden for glasbrud i anordninger til indgivelse af lægemidler
|
|
US11001624B2
(en)
*
|
2016-04-05 |
2021-05-11 |
Vib Vzw |
TSLP inhibitors
|
|
WO2017189089A1
(en)
|
2016-04-29 |
2017-11-02 |
Amgen Inc. |
Drug delivery device with messaging label
|
|
US11389588B2
(en)
|
2016-05-02 |
2022-07-19 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
|
WO2017197222A1
(en)
|
2016-05-13 |
2017-11-16 |
Amgen Inc. |
Vial sleeve assembly
|
|
EP3458988B1
(en)
|
2016-05-16 |
2023-10-18 |
Amgen Inc. |
Data encryption in medical devices with limited computational capability
|
|
EP3465124A1
(en)
|
2016-06-03 |
2019-04-10 |
Amgen Inc. |
Impact testing apparatuses and methods for drug delivery devices
|
|
TWI802193B
(zh)
|
2016-06-14 |
2023-05-11 |
美商默沙東有限責任公司 |
抗凝血因子ｘｉ抗體
|
|
US11285266B2
(en)
|
2016-07-01 |
2022-03-29 |
Amgen Inc. |
Drug delivery device having minimized risk of component fracture upon impact events
|
|
US10919966B2
(en)
*
|
2016-08-05 |
2021-02-16 |
Y-Biologics Inc. |
Antibody to programmed death-ligand 1 (PD-L1) and use thereof
|
|
WO2018034784A1
(en)
|
2016-08-17 |
2018-02-22 |
Amgen Inc. |
Drug delivery device with placement detection
|
|
WO2018081234A1
(en)
|
2016-10-25 |
2018-05-03 |
Amgen Inc. |
On-body injector
|
|
TWI857389B
(zh)
|
2016-12-01 |
2024-10-01 |
美商再生元醫藥公司 |
治療發炎症狀的方法
|
|
MX2019008432A
(es)
|
2017-01-17 |
2019-11-18 |
Amgen Inc |
Dispositivos de inyeccion y metodos relacionados de uso y ensamblaje.
|
|
PL3383916T3
(pl)
*
|
2017-01-24 |
2023-06-12 |
I-Mab Biopharma Us Limited |
Przeciwciała anty-cd73 i ich zastosowania
|
|
MX2019009755A
(es)
|
2017-02-17 |
2019-10-07 |
Amgen Inc |
Mecanismo de insercion para dispositivo de suministro de farmacos.
|
|
US11752258B2
(en)
|
2017-02-17 |
2023-09-12 |
Amgen Inc. |
Drug delivery device with sterile fluid flowpath and related method of assembly
|
|
JP7377596B2
(ja)
|
2017-02-22 |
2023-11-10 |
アムジエン・インコーポレーテツド |
低粘度、高濃度エボロクマブ製剤及びそれらの製造方法
|
|
AU2018231107B2
(en)
|
2017-03-06 |
2023-04-20 |
Amgen Inc. |
Drug delivery device with activation prevention feature
|
|
EP3592402A1
(en)
|
2017-03-07 |
2020-01-15 |
Amgen Inc. |
Needle insertion by overpressure
|
|
EP3592404A1
(en)
|
2017-03-09 |
2020-01-15 |
Amgen Inc. |
Insertion mechanism for drug delivery device
|
|
EP3596225A1
(en)
|
2017-03-14 |
2020-01-22 |
Amgen Inc. |
Control of total afucosylated glycoforms of antibodies produced in cell culture
|
|
EP4241807B1
(en)
|
2017-03-28 |
2025-02-19 |
Amgen Inc. |
Plunger rod and syringe assembly system
|
|
JOP20190243A1
(ar)
|
2017-04-12 |
2019-10-13 |
Medimmune Llc |
علاج الربو بجسم مضاد لـ tslp
|
|
MA48464A
(fr)
|
2017-04-28 |
2020-03-04 |
Amgen Inc |
Dipeptides n-acétylés et non acétylés contenant de l'arginine destinés à réduire la viscosité de compositions visqueuses de polypeptides thérapeutiques
|
|
AU2018280054B2
(en)
|
2017-06-08 |
2023-07-13 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
|
AU2018282077B2
(en)
|
2017-06-08 |
2023-11-23 |
Amgen Inc. |
Torque driven drug delivery device
|
|
MA49447A
(fr)
|
2017-06-22 |
2020-04-29 |
Amgen Inc |
Réduction des impacts/chocs d'activation d'un dispositif
|
|
WO2018237225A1
(en)
|
2017-06-23 |
2018-12-27 |
Amgen Inc. |
Electronic drug delivery device comprising a cap activated by a switch assembly
|
|
CN109206514B
(zh)
*
|
2017-07-03 |
2019-10-08 |
拜西欧斯（北京）生物技术有限公司 |
Tslp单克隆抗体及其制备方法和应用
|
|
MA49562A
(fr)
|
2017-07-14 |
2020-05-20 |
Amgen Inc |
Système d'insertion-rétractation d'aiguille présentant un système à ressort en double torsion
|
|
EP3655063A1
(en)
|
2017-07-21 |
2020-05-27 |
Amgen Inc. |
Gas permeable sealing member for drug container and methods of assembly
|
|
US11484648B2
(en)
|
2017-07-25 |
2022-11-01 |
Amgen Inc. |
Drug delivery device with container access system and related method of assembly
|
|
EP3658203B2
(en)
|
2017-07-25 |
2025-10-01 |
Amgen Inc. |
Drug delivery device with gear module and related method of assembly
|
|
KR102577670B1
(ko)
|
2017-08-01 |
2023-09-12 |
암젠 인크 |
샘플의 실시간 글리칸 분석을 수행하기 위한 시스템 및 방법
|
|
WO2019028187A1
(en)
|
2017-08-01 |
2019-02-07 |
Amgen Inc. |
SYSTEMS AND METHODS FOR REAL-TIME PREPARATION OF A POLYPEPTIDE SAMPLE FOR MASS SPECTROMETRY ANALYSIS
|
|
MA49838A
(fr)
|
2017-08-09 |
2020-06-17 |
Amgen Inc |
Systèm de administration de médicaments avec pression hydraulique-pneumatique de chambre
|
|
EP3669004A1
(en)
|
2017-08-16 |
2020-06-24 |
Medimmune, LLC |
Compositions and methods for treatment of atopic dermatitis and treatment selection
|
|
MA49897A
(fr)
|
2017-08-18 |
2020-06-24 |
Amgen Inc |
Injecteur sur-corps avec patch adhésif stérile
|
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
|
MA50611A
(fr)
|
2017-10-04 |
2020-08-12 |
Amgen Inc |
Adaptateur d'écoulement destiné à un dispositif d'administration de médicament
|
|
IL272636B2
(en)
|
2017-10-06 |
2024-10-01 |
Amgen Inc |
Drug delivery device with interlock assembly and related method of assembly
|
|
IL273323B2
(en)
|
2017-10-09 |
2024-10-01 |
Amgen Inc |
Drug delivery device with drive assembly and related assembly method
|
|
EA202090817A1
(ru)
|
2017-10-13 |
2020-09-08 |
Харпун Терапьютикс, Инк. |
Триспецифические белки и способы их применения
|
|
IL315737A
(en)
|
2017-10-13 |
2024-11-01 |
Harpoon Therapeutics Inc |
B-cell maturation antigen-binding proteins
|
|
EP3703778A1
(en)
|
2017-11-03 |
2020-09-09 |
Amgen Inc. |
System and approaches for sterilizing a drug delivery device
|
|
EP3707075A1
(en)
|
2017-11-06 |
2020-09-16 |
Amgen Inc. |
Fill-finish assemblies and related methods
|
|
US20200261648A1
(en)
|
2017-11-06 |
2020-08-20 |
Amgen Inc. |
Drug delivery device with placement and flow sensing
|
|
CN111225696B
(zh)
|
2017-11-10 |
2023-07-18 |
安进公司 |
用于药物递送装置的柱塞
|
|
WO2019099324A1
(en)
|
2017-11-16 |
2019-05-23 |
Amgen Inc. |
Door latch mechanism for drug delivery device
|
|
EP4321870B1
(en)
|
2018-03-13 |
2025-07-30 |
Amgen Inc. |
Methods for the preparation of trypsin-resistant polypeptides for mass spectrometric analysis
|
|
WO2019178280A1
(en)
|
2018-03-13 |
2019-09-19 |
Amgen Inc. |
Sequential digestion of polypeptides for mass spectrometric analysis
|
|
CN111954719B
(zh)
|
2018-03-26 |
2025-07-18 |
美国安进公司 |
细胞培养物中产生的抗体的总去岩藻糖基化糖型
|
|
SG11202011330PA
(en)
|
2018-05-14 |
2020-12-30 |
Harpoon Therapeutics Inc |
Binding moiety for conditional activation of immunoglobulin molecules
|
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
|
EP3826701A1
(en)
|
2018-07-24 |
2021-06-02 |
Amgen Inc. |
Delivery devices for administering drugs
|
|
WO2020023336A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
|
WO2020023451A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Delivery devices for administering drugs
|
|
WO2020023220A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with tacky skin attachment portion and related method of preparation
|
|
CA3103105A1
(en)
|
2018-07-31 |
2020-02-06 |
Amgen Inc. |
Fluid path assembly for a drug delivery device
|
|
WO2020061482A1
(en)
|
2018-09-21 |
2020-03-26 |
Harpoon Therapeutics, Inc. |
Egfr binding proteins and methods of use
|
|
MA53724A
(fr)
|
2018-09-24 |
2021-12-29 |
Amgen Inc |
Systèmes et procédés de dosage interventionnel
|
|
AU2019346466A1
(en)
|
2018-09-25 |
2021-05-20 |
Harpoon Therapeutics, Inc. |
DLL3 binding proteins and methods of use
|
|
CA3110371A1
(en)
|
2018-09-28 |
2020-04-02 |
Amgen Inc. |
Muscle wire escapement activation assembly for a drug delivery device
|
|
AU2019352616B2
(en)
|
2018-10-02 |
2024-10-10 |
Amgen Inc. |
Injection systems for drug delivery with internal force transmission
|
|
TW202529830A
(zh)
|
2018-10-05 |
2025-08-01 |
美商安進公司 |
具有劑量指示器之藥物遞送裝置
|
|
SG11202101824VA
(en)
|
2018-10-15 |
2021-03-30 |
Amgen Inc |
Platform assembly process for drug delivery device
|
|
EA202191037A1
(ru)
|
2018-10-15 |
2021-08-05 |
Эмджен Инк. |
Устройство доставки лекарственного средства, имеющее демпферный механизм
|
|
TWI831847B
(zh)
|
2018-11-01 |
2024-02-11 |
美商安進公司 |
部分針頭縮回之藥物遞送裝置及其操作方法
|
|
EP3873563A1
(en)
|
2018-11-01 |
2021-09-08 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
|
WO2020091956A1
(en)
|
2018-11-01 |
2020-05-07 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
|
US12000775B2
(en)
|
2018-12-14 |
2024-06-04 |
Amgen Inc. |
System suitability method for use with protein concentration determination by slope
|
|
US11452738B2
(en)
|
2019-01-04 |
2022-09-27 |
Empirico Inc. |
Treatment of thymic stromal lymphopoietin (TSLP) related diseases by inhibition of long-form TSLP transcripts
|
|
WO2020168156A1
(en)
|
2019-02-14 |
2020-08-20 |
Amgen Inc. |
Systems and methods for preparing a sample and performing a real-time assay of the sample
|
|
US12493019B2
(en)
|
2019-02-20 |
2025-12-09 |
Amgen Inc. |
Methods of determining protein stability
|
|
JP7570341B2
(ja)
|
2019-03-04 |
2024-10-21 |
アムジエン・インコーポレーテツド |
高分子量種のインビボでの可逆性
|
|
EP3948242A1
(en)
|
2019-03-27 |
2022-02-09 |
Amgen Inc. |
Methods of fingerprinting therapeutic proteins via a two-dimensional (2d) nuclear magnetic resonance technique at natural abundance for formulated biopharmaceutical products
|
|
US20220160972A1
(en)
|
2019-04-24 |
2022-05-26 |
Amgen Inc. |
Syringe sterilization verification assemblies and methods
|
|
CN116751295A
(zh)
|
2019-06-04 |
2023-09-15 |
江苏恒瑞医药股份有限公司 |
能结合胸腺基质淋巴细胞生成素的抗体及其应用
|
|
EP4517327A3
(en)
|
2019-06-05 |
2025-05-07 |
Amgen Inc. |
Methods of identifying attributes of therapeutic proteins
|
|
CA3147044A1
(en)
|
2019-07-11 |
2021-01-14 |
Tavotek Biotherapeutics (Hong Kong) Limited |
Agents that interfere with thymic stromal lymphopoietin (tslp)-receptor signaling
|
|
WO2021041067A2
(en)
|
2019-08-23 |
2021-03-04 |
Amgen Inc. |
Drug delivery device with configurable needle shield engagement components and related methods
|
|
BR112022005583A2
(pt)
|
2019-09-26 |
2022-09-20 |
Amgen Inc |
Métodos para a produção de composições de anticorpos
|
|
IL292437A
(en)
|
2019-10-28 |
2022-06-01 |
Medimmune Ltd |
Dry powder formulations of antibodies that bind thymic lymphopoietin (tslp) and methods of using them
|
|
CN114887053A
(zh)
*
|
2019-11-29 |
2022-08-12 |
康诺亚生物医药科技（成都）有限公司 |
一种tslp相关病症治疗剂的开发和应用
|
|
US20220363781A1
(en)
*
|
2019-12-13 |
2022-11-17 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Anti-tslp antibody and uses thereof
|
|
TW202140550A
(zh)
|
2020-01-29 |
2021-11-01 |
瑞士商諾華公司 |
使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法
|
|
CN111171150B
(zh)
*
|
2020-02-05 |
2020-12-08 |
北京智仁美博生物科技有限公司 |
抗人tslp抗体及其用途
|
|
EP4103605A1
(en)
|
2020-02-13 |
2022-12-21 |
Amgen Inc. |
Treatment of atopic dermatitis with anti-tslp antibody
|
|
AU2021219839A1
(en)
|
2020-02-13 |
2022-08-25 |
Amgen Inc. |
Formulations of human anti-TSLP antibodies and methods of treating inflammatory disease
|
|
JP2023513833A
(ja)
|
2020-02-18 |
2023-04-03 |
アムジェン インコーポレイテッド |
ヒト抗ｔｓｌｐ抗体の製剤及びそれを使用する方法
|
|
CN111662379B
(zh)
*
|
2020-05-09 |
2021-03-02 |
江苏省疾病预防控制中心(江苏省公共卫生研究院) |
抗新型冠状病毒的抗体、制备方法和应用
|
|
JP2023526469A
(ja)
*
|
2020-05-20 |
2023-06-21 |
ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク |
ＳＡＲＳ－ＣｏＶ－２に対する強力な中和抗体、その生成および使用
|
|
US20230273126A1
(en)
|
2020-06-04 |
2023-08-31 |
Amgen Inc. |
Assessment of cleaning procedures of a biotherapeutic manufacturing process
|
|
MX2023003164A
(es)
|
2020-09-18 |
2023-05-04 |
Amgen Inc |
Metodos de procesamiento de una muestra para analisis de mapeo de peptidos.
|
|
AU2021360897A1
(en)
|
2020-10-15 |
2023-05-25 |
Amgen Inc. |
Relative unpaired glycans in antibody production methods
|
|
MX2023005320A
(es)
|
2020-11-05 |
2023-05-19 |
Amgen Inc |
Materiales y metodos para el procesamiento de proteinas.
|
|
CN114437212B
(zh)
*
|
2020-11-06 |
2023-03-14 |
上海麦济生物技术有限公司 |
抗人胸腺基质淋巴细胞生成素抗体及其制备方法和应用
|
|
WO2022117079A1
(zh)
*
|
2020-12-03 |
2022-06-09 |
江苏恒瑞医药股份有限公司 |
结合胸腺基质淋巴细胞生成素的抗体及其应用
|
|
CN113501878B
(zh)
|
2021-02-03 |
2022-12-02 |
北京智仁美博生物科技有限公司 |
针对人tslp的多种抗体及其用途
|
|
KR20230140571A
(ko)
*
|
2021-02-04 |
2023-10-06 |
스테이드슨 (베이징) 바이오팔마슈티칼스 캄퍼니 리미티드 |
흉선 기질 림포포이에틴을 특이적으로 인식하는 항체 및 이의 용도
|
|
IL307439A
(en)
|
2021-04-23 |
2023-12-01 |
Amgen Inc |
Different anti-TSLP antibodies
|
|
BR112023021867A2
(pt)
|
2021-04-23 |
2023-12-19 |
Amgen Inc |
Composições de anticorpo anti-tslp e seus usos
|
|
EP4341161A1
(en)
|
2021-05-21 |
2024-03-27 |
Amgen Inc. |
Method of optimizing a filling recipe for a drug container
|
|
AU2022285961A1
(en)
*
|
2021-05-30 |
2023-12-14 |
Biolojic Design Ltd. |
Engineered dual binding antibodies and uses thereof
|
|
CN113069543B
(zh)
*
|
2021-06-07 |
2021-08-06 |
迈威(上海)生物科技股份有限公司 |
包含抗胸腺基质淋巴细胞生成素的单克隆抗体的液体组合物
|
|
AU2022289365A1
(en)
|
2021-06-07 |
2023-12-14 |
Amgen Inc. |
Using fucosidase to control afucosylation level of glycosylated proteins
|
|
CN113683694B
(zh)
|
2021-09-03 |
2022-05-13 |
江苏荃信生物医药股份有限公司 |
一种抗人tslp单克隆抗体及其应用
|
|
WO2023059607A1
(en)
|
2021-10-05 |
2023-04-13 |
Amgen Inc. |
Fc-gamma receptor ii binding and glycan content
|
|
WO2023070948A1
(zh)
*
|
2021-11-01 |
2023-05-04 |
江苏荃信生物医药股份有限公司 |
包含抗人胸腺基质淋巴细胞生成素(tslp)单克隆抗体的浓缩溶液的制备方法及液体制剂
|
|
CA3237662A1
(en)
|
2021-11-09 |
2023-05-19 |
Amgen Inc. |
Production of therapeutic proteins
|
|
CN116217724B
(zh)
*
|
2021-12-02 |
2023-10-27 |
北京东方百泰生物科技股份有限公司 |
一种抗tslp的单克隆抗体、其抗原结合片段及其应用
|
|
CN114369654B
(zh)
*
|
2021-12-21 |
2023-11-07 |
广州市妇女儿童医疗中心 |
川崎病的生物标志物及其应用
|
|
IL313679A
(en)
*
|
2021-12-24 |
2024-08-01 |
Inmagene Pte Ltd |
Novel anti-tslp antibodies
|
|
MX2024010773A
(es)
*
|
2022-03-03 |
2024-09-10 |
Pfizer |
Anticuerpos multiespecificos y usos de estos.
|
|
WO2023215725A1
(en)
|
2022-05-02 |
2023-11-09 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
|
US12110324B2
(en)
*
|
2022-07-22 |
2024-10-08 |
Flagship Pioneering Innovations Vi, Llc |
Antigen binding molecules targeting thymic stromal lymphopoietin (TSLP)
|
|
CN118772266B
(zh)
*
|
2022-10-21 |
2025-06-17 |
珠海泰诺麦博制药股份有限公司 |
抗人巨细胞病毒抗体及其用途
|
|
UY40500A
(es)
|
2022-10-26 |
2024-04-30 |
Amgen Inc |
Composiciones de anticuerpos anti-tslp y usos de las mismas
|
|
TW202448501A
(zh)
|
2023-02-02 |
2024-12-16 |
美商麥迪紐有限責任公司 |
用抗ｔｓｌｐ抗體治療慢性鼻竇炎
|
|
CN120659807A
(zh)
*
|
2023-02-23 |
2025-09-16 |
四川科伦博泰生物医药股份有限公司 |
一种靶向tslp的单克隆抗体制剂
|
|
WO2024220916A1
(en)
|
2023-04-20 |
2024-10-24 |
Amgen Inc. |
Methods of determining relative unpaired glycan content
|
|
TW202509066A
(zh)
|
2023-05-18 |
2025-03-01 |
美商麥迪紐有限責任公司 |
用抗ｔｓｌｐ抗體治療皮質類固醇依賴性氣喘
|
|
WO2024259275A1
(en)
|
2023-06-14 |
2024-12-19 |
Bristol-Myers Squibb Company |
Near real time sialic acid quantitation of glycoproteins
|
|
WO2024264003A2
(en)
*
|
2023-06-22 |
2024-12-26 |
Paragon Therapeutics, Inc. |
Antibodies that bind interleukin 13 and tslp or tslpr and methods of use
|
|
WO2024264002A2
(en)
*
|
2023-06-22 |
2024-12-26 |
Paragon Therapeutics, Inc. |
Antibodies that bind tslp and tslpr and methods of use
|
|
WO2025038600A1
(en)
|
2023-08-14 |
2025-02-20 |
Amgen Inc. |
Methods for reducing yellow color
|
|
TW202525846A
(zh)
|
2023-08-25 |
2025-07-01 |
美商普羅特歐拉吉克適美國公司 |
抗ｉｌ—１３多特異性抗體構築體及其用途
|
|
TW202530266A
(zh)
*
|
2023-10-12 |
2025-08-01 |
大陸商信達生物製藥（蘇州）有限公司 |
抗ＩＬ－４Ｒα抗體及其用途
|
|
WO2025101602A1
(en)
|
2023-11-07 |
2025-05-15 |
Amgen Inc. |
Methods of analyzing amino acid content of a therapeutic protein
|
|
WO2025101820A1
(en)
|
2023-11-08 |
2025-05-15 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
|
WO2025147632A1
(en)
|
2024-01-05 |
2025-07-10 |
Medimmune, Llc |
Treatment of chronic obstructive pulmonary disease with anti-tslp antibody
|
|
WO2025221247A1
(en)
|
2024-04-17 |
2025-10-23 |
Amgen Inc. |
Treatment of eosinophilic esophagitis with anti-tslp antibody
|
|
WO2025255028A1
(en)
|
2024-06-03 |
2025-12-11 |
Amgen Inc. |
High-throughput liquid chromatography-mass spectrometry-based peptide mapping
|